Arcadia Biosciences, Inc. (RKDA) stock
RKDANasdaqBeveragesFiscal year ends December 31
$0.19−0.02 (-11.19%)
Close on Nov 16, 2026Market cap $466.42KP/E –Yield –
Arcadia Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Arcadia Biosciences's enterprise value was -$3.66M on Nov 11, 2026, against -$975.25K a year earlier. Over the last 5 years it ranged from -$19.80M to $5.83M, with a median of -$3.83M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$3.66M | – |
| 2025 | Dec 31, 2025 | -$3.18M | -332.5% |
| 2024 | Dec 31, 2024 | $1.37M | – |
| 2023 | Dec 29, 2023 | -$12.36M | – |
| 2022 | Dec 30, 2022 | -$16.09M | – |
| 2021 | Dec 31, 2021 | -$11.96M | -156.5% |
| 2020 | Dec 31, 2020 | $21.18M | +22.5% |
| 2019 | Dec 31, 2019 | $17.29M | – |
| 2018 | Dec 31, 2018 | -$9.46M | – |
| 2017 | Dec 29, 2017 | -$3.96M | -132.7% |
| 2016 | Dec 30, 2016 | $12.11M | -84.6% |
| 2015 | Dec 31, 2015 | $78.76M | – |
See a number that looks wrong?